RAPT Therapeutics, Inc. (RAPT) Tops Q3 EPS by 9c

RAPT Therapeutics, Inc. (NASDAQ: RAPT) reported Q3 EPS of ($0.47), $0.09 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on RAPT Therapeutics, Inc. (RAPT) click here.

You May Also Be Interested In

• SpaceX shares gain as lock-up fears ease
• Leerink Downgrades Exelixis (EXEL) to Market Perform
• BKV Corporation (BKV) 5200 contracts of November 25 calls trade, share price up 3.7%